Evidence map›Paper›PMID 25425649›Full record

ArticleThe Journal of biological chemistry2015

Variomics screen identifies the re-entrant loop of the calcium-activated chloride channel ANO1 that facilitates channel activation.

Anke Bill, M Oana Popa, Michiel T van Diepen, Abraham Gutierrez, Sarah Lilley, Maria Velkova, Kathryn Acheson, Hedaythul Choudhury, Nicole A Renaud, Douglas S Auld and 3 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. TMEM16A as a potential treatment target for head and neck cancer.Journal of experimental & clinical cancer research : CR · 2022
    Review
  3. Article
  4. Lysosomal inhibition sensitizes TMEM16A-expressing cancer cells to chemotherapy.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  5. Article
  6. Article
  7. TMEM16A Potentiation: A Novel Therapeutic Approach for the Treatment of Cystic Fibrosis.American journal of respiratory and critical care medicine · 2020
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Four basic residues critical for the ion selectivity and pore blocker sensitivity of TMEM16A calcium-activated chloride channels.Proceedings of the National Academy of Sciences of the United States of America · 2015
    Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Anke BillFrom the Novartis Institutes for Biomedical Research, Cambridge, Massachusetts 02139.
M Oana Popathe Novartis Institutes for Biomedical Research, Horsham, West Sussex RH12 5AB, United Kingdom, and.
Michiel T van Diepenthe Novartis Institutes for Biomedical Research, Horsham, West Sussex RH12 5AB, United Kingdom, and.
Abraham GutierrezFrom the Novartis Institutes for Biomedical Research, Cambridge, Massachusetts 02139.
Sarah Lilleythe Novartis Institutes for Biomedical Research, Horsham, West Sussex RH12 5AB, United Kingdom, and.
Maria Velkovathe Novartis Institutes for Biomedical Research, Horsham, West Sussex RH12 5AB, United Kingdom, and.
Kathryn Achesonthe Novartis Institutes for Biomedical Research, Horsham, West Sussex RH12 5AB, United Kingdom, and.
Hedaythul Choudhurythe Novartis Institutes for Biomedical Research, Horsham, West Sussex RH12 5AB, United Kingdom, and.
Nicole A RenaudFrom the Novartis Institutes for Biomedical Research, Cambridge, Massachusetts 02139.
Douglas S AuldFrom the Novartis Institutes for Biomedical Research, Cambridge, Massachusetts 02139.
Martin Goslingthe Novartis Institutes for Biomedical Research, Horsham, West Sussex RH12 5AB, United Kingdom, and.
Paul J Groot-Kormelinkthe Novartis Institutes for Biomedical Research, Basel CH-4002, Switzerland.
L Alex GaitherFrom the Novartis Institutes for Biomedical Research, Cambridge, Massachusetts 02139, alex.gaither@novartis.com.
Novartis (Switzerland) · CHNovartis Institutes for BioMedical Research

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The calcium-activated chloride channel ANO1 regulates multiple physiological processes. However, little is known about the mechanism of channel gating and regulation of ANO1 activity. Using a high-throughput, random mutagenesis-based variomics screen, we generated and functionally characterized ∼6000 ANO1 mutants and identified novel mutations that affected channel activity, intracellular trafficking, or localization of ANO1. Mutations such as S741T increased ANO1 calcium sensitivity and rendered ANO1 calcium gating voltage-independent, demonstrating a critical role of the re-entrant loop in coupling calcium and voltage sensitivity of ANO1 and hence in regulating ANO1 activation. Our data present the first unbiased and comprehensive study of the structure-function relationship of ANO1. The novel ANO1 mutants reported have diverse functional characteristics, providing new tools to study ANO1 function in biological systems, paving the path for a better understanding of the function of ANO1 and its role in health and diseases.

Indexed as

Structure-Activity RelationshipAnimalsAnoctamin-1Chloride ChannelsCHO CellsCricetulusHEK293 CellsHumansIon ChannelsMutagenesis, Site-DirectedNeoplasm ProteinsProtein ConformationANO1 protein, humanAnoctamin-1Chloride ChannelsIon ChannelsNeoplasm ProteinsANO1Chloride ChannelIon ChannelMutagenesisProtein StructureSite-directed MutagenesisTMEM16AVariomics

Identifiers

PMID25425649
PMCPMC4294516
OpenAlexW2083575187

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.